Intersect ENT Reports Second Quarter 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street closes lower as oil prices jump, indexes notch monthly gains
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
- BofA turns S&P 500 signals from red to yellow: What to buy now
Intersect ENT (XENT) Tops Q2 EPS by 3c, FY Revenue Guidance Misses
August 1, 2018 8:41 AM EDTIntersect ENT (NASDAQ: XENT) reported Q2 EPS of ($0.14), $0.03 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $26.3 million versus the consensus estimate of $28.15 million.
Outlook
The company expects to achieve third quarter revenue in the range of $23.8 to $24.3 million,... More
